JP2024501796A5 - - Google Patents
Info
- Publication number
- JP2024501796A5 JP2024501796A5 JP2023536468A JP2023536468A JP2024501796A5 JP 2024501796 A5 JP2024501796 A5 JP 2024501796A5 JP 2023536468 A JP2023536468 A JP 2023536468A JP 2023536468 A JP2023536468 A JP 2023536468A JP 2024501796 A5 JP2024501796 A5 JP 2024501796A5
- Authority
- JP
- Japan
- Prior art keywords
- transmembrane protein
- cells
- protein
- human
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130044P | 2020-12-23 | 2020-12-23 | |
| US63/130,044 | 2020-12-23 | ||
| PCT/US2021/064769 WO2022140494A1 (en) | 2020-12-23 | 2021-12-22 | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024501796A JP2024501796A (ja) | 2024-01-16 |
| JP2024501796A5 true JP2024501796A5 (https=) | 2024-12-27 |
Family
ID=82022075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536468A Pending JP2024501796A (ja) | 2020-12-23 | 2021-12-22 | 膜貫通タンパク質に結合する抗体、および抗体を産生する細胞を取得する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12371487B2 (https=) |
| EP (1) | EP4267608A1 (https=) |
| JP (1) | JP2024501796A (https=) |
| KR (1) | KR20230124594A (https=) |
| CN (1) | CN116635413A (https=) |
| AU (1) | AU2021409906A1 (https=) |
| BR (1) | BR112023011689A2 (https=) |
| CA (1) | CA3197426A1 (https=) |
| IL (1) | IL303865A (https=) |
| MX (1) | MX2023007583A (https=) |
| TW (1) | TW202242114A (https=) |
| WO (1) | WO2022140494A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116622754A (zh) * | 2023-05-31 | 2023-08-22 | 南开大学 | 一种定点标记的跨膜蛋白纳米盘及其制备方法和应用 |
| CN118027202B (zh) * | 2024-03-14 | 2024-08-13 | 恺佧生物科技(上海)有限公司 | 结合slc13a5膜蛋白的抗体 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| DK1345959T3 (da) | 2000-11-20 | 2011-09-05 | Univ Illinois | Membranscaffoldproteiner |
| JP4939926B2 (ja) | 2003-02-14 | 2012-05-30 | アノシス・インコーポレーテッド | 抗体を生成し抗体レパートリーをスクリーニングするための方法とコンパウンド |
| WO2006058890A2 (en) * | 2004-11-30 | 2006-06-08 | Novo Nordisk A/S | Method of producing antibodies |
| EP1910513B1 (en) * | 2005-07-01 | 2016-08-10 | John Schrader | Methods of isolating antibody secreting cells from blood samples of immunized animals and generating monoclonal antibodies from said antibody secreting cells. |
| EP2121007A1 (en) | 2006-12-21 | 2009-11-25 | Cytos Biotechnology AG | Circular ccr5 peptide conjugates and uses thereof |
| GB2456236B8 (en) | 2007-03-22 | 2009-12-09 | Heptares Therapeutics Ltd | Stable muscarinic receptor mutants |
| US20130185821A1 (en) | 2010-02-08 | 2013-07-18 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
| US20120021409A1 (en) | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
| SMT202600080T1 (it) | 2010-02-08 | 2026-03-09 | Regeneron Pharma | Topo con catena leggera comune |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| PT3034608T (pt) | 2010-06-22 | 2019-05-28 | Regeneron Pharma | Ratinhos expressando uma cadeia leve híbrida de imunoglobulina com uma região variável humana |
| ME02106B (me) | 2011-02-25 | 2015-10-20 | Regeneron Pharma | Miševi sa adam6 |
| EP2617732A1 (en) | 2012-01-19 | 2013-07-24 | Vib Vzw | Tools and methods for expression of membrane proteins |
| MX353278B (es) | 2012-03-06 | 2018-01-05 | Regeneron Pharma | Raton con cadena ligera comun. |
| ES2676827T3 (es) | 2012-06-01 | 2018-07-25 | Heptares Therapeutics Limited | Ensayos |
| MX2014014891A (es) | 2012-06-05 | 2015-06-17 | Regeneron Pharma | Metodos para hacer anticuerpos biespecificos completamente humanos usando una cadena ligera comun. |
| EP2745834B1 (en) | 2012-12-18 | 2016-09-28 | Jens Frauenfeld | Salipro particles |
| HK1218550A1 (zh) | 2013-03-13 | 2017-02-24 | Regeneron Pharmaceuticals, Inc. | 常見輕鏈小鼠 |
| EP4545567A3 (en) | 2013-03-13 | 2025-08-13 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| US9850303B2 (en) | 2013-03-15 | 2017-12-26 | The Translational Genomics Research Institute | Hybridoma clones and monoclonal antibodies to tetraspanin 8 |
| ES2939555T3 (es) * | 2014-11-14 | 2023-04-24 | Regeneron Pharma | Método para generar anticuerpos de alta afinidad |
| WO2017214089A1 (en) | 2016-06-06 | 2017-12-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing antibodies with human lambda light chains |
| EP3284460A1 (en) | 2016-08-19 | 2018-02-21 | Salipro Biotech AG | Saposin lipoprotein particles and libraries from crude membranes |
| SG10201913483XA (en) | 2016-11-04 | 2020-03-30 | Regeneron Pharma | Non-human animals having an engineered immunoglobulin lambda light chain locus |
| HUE060608T2 (hu) | 2017-12-05 | 2023-03-28 | Regeneron Pharma | Genetikailag módosított immunglobulin lambda könnyûlánccal rendelkezõ egerek és azok alkalmazása |
| US20210214719A1 (en) | 2018-05-31 | 2021-07-15 | Kangti Pte. Ltd. | A yeast phenotypic screening method for isolation of functional antibodies against g-protein coupled receptors |
| US20210299070A1 (en) | 2018-09-21 | 2021-09-30 | Jnana Therapeutics, Inc. | Methods of treating creatine transporter deficiency |
| US20210371403A1 (en) | 2018-09-21 | 2021-12-02 | Jnana Therapeutics, Inc. | Small molecules targeting mutant mammalian proteins |
| WO2020061476A1 (en) | 2018-09-21 | 2020-03-26 | Jnana Therapeutics, Inc. | Small molecules targeting mutant mammalian proteins |
-
2021
- 2021-12-22 IL IL303865A patent/IL303865A/en unknown
- 2021-12-22 KR KR1020237021168A patent/KR20230124594A/ko active Pending
- 2021-12-22 CA CA3197426A patent/CA3197426A1/en active Pending
- 2021-12-22 CN CN202180086859.7A patent/CN116635413A/zh active Pending
- 2021-12-22 US US17/558,645 patent/US12371487B2/en active Active
- 2021-12-22 AU AU2021409906A patent/AU2021409906A1/en active Pending
- 2021-12-22 BR BR112023011689A patent/BR112023011689A2/pt unknown
- 2021-12-22 MX MX2023007583A patent/MX2023007583A/es unknown
- 2021-12-22 TW TW110148096A patent/TW202242114A/zh unknown
- 2021-12-22 JP JP2023536468A patent/JP2024501796A/ja active Pending
- 2021-12-22 EP EP21847855.0A patent/EP4267608A1/en active Pending
- 2021-12-22 WO PCT/US2021/064769 patent/WO2022140494A1/en not_active Ceased
-
2025
- 2025-06-20 US US19/243,816 patent/US20250313624A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9487583B2 (en) | Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies | |
| US10429386B2 (en) | Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof | |
| JP2004520037A5 (https=) | ||
| JP2012518390A5 (https=) | ||
| FI3894549T3 (fi) | Mutatoitu piggybac-transposaasi | |
| JP2024501796A5 (https=) | ||
| Price et al. | Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas | |
| WO2023010118A1 (en) | Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same | |
| Li et al. | Naked2 acts as a cargo recognition and targeting protein to ensure proper delivery and fusion of TGF-α–containing exocytic vesicles at the lower lateral membrane of polarized MDCK cells | |
| CN114340660A (zh) | 开发用于发现治疗性抗体的高效杂交瘤平台 | |
| Challa et al. | Function-first discovery of high affinity monoclonal antibodies using Nanovial-based plasma B cell screening | |
| CN102282256B (zh) | 针对在细胞表面表达的蛋白质的抗体制作方法 | |
| CN115667304B (zh) | 抗人lag-3抗体及其在免疫组织化学(ihc)中的用途 | |
| CN116635413A (zh) | 用于获得结合跨膜蛋白的抗体的方法和生产所述抗体的细胞 | |
| MX2012009942A (es) | Vector de expresion. | |
| JP5230397B2 (ja) | 抗膜貫通型タンパク質抗体の抗原結合部位を決定する方法 | |
| JP6742590B2 (ja) | 抗体又はその抗原結合性フラグメント及びハイブリドーマ | |
| CN118388658A (zh) | 一种靶向nmda受体人源抗体的筛选方法 | |
| JP2019048794A (ja) | 抗体産生細胞のスクリーニング用検出プローブ及びその使用 | |
| JP2022181707A (ja) | 非変性チャネルロドプシン検出キット | |
| CN1918299A (zh) | 用于生产拴系蛋白的方法 | |
| JP5638747B2 (ja) | がん腫の遺伝子診断のための細胞回収及び単離方法並びにキット | |
| RU2845938C1 (ru) | Клеточный анализ для определения активности киллинга опухолевых клеток, экспрессирующих химерные антигены иммунных клеток in vitro | |
| US20120322083A1 (en) | Antibody binding to abca1 polypeptide | |
| CN112940122B (zh) | 靶向dnam-1的鼠单链抗体、表达所述鼠单链抗体的重组质粒、重组细胞及应用 |